Table 1. Baseline Characteristics; Pretreatment and Posttreatment Outcomes as well as Complications of Patients of Both Groups.
ILIB | Sham Laser | P Value | |
Patients, No. | 10 | 10 | |
Mean age, year ± SD | 65.2±22.9 | 64.8±19.7 | 0.9 |
Male to female ratio (%) | 70 | 70 | NS |
Need for dialysis (%) | 2 (20) | 2 (20) | NS |
Mean serum sodium, mmol/L ± SD | |||
Pretreatment | 142.2±4.8 | 140.1±4.7 | 0.3 |
Posttreatment | 134.7±1.6 | 134.9±1.7 | 0.7 |
P value | 0. 003* | 0.013* | - |
Mean serum potassium, mmol/L ± SD | |||
Pretreatment | 5.5±0.7 | 6.3±1.01 | 0.5 |
Posttreatment | 4.0±0.1 | 4.03±0.3 | 0.8 |
P value | 0. 0001* | 0.0001* | - |
Mean serum phosphor, mmol/L ± SD | |||
Pretreatment | 6.4±1.1 | 6.3±1.01 | 0.8 |
Posttreatment | 2.9±0.7 | 3.0±0.7 | 0.7 |
P value | 0. 0001* | 0.0001* | - |
Mean serum BUN, mmol/L ± SD | |||
Pretreatment | 92.7±38.4 | 83.6±29.7 | 0.5 |
Posttreatment | 26.6±8.1 | 29.2±7.6 | 0.5 |
P value | 0. 0001* | 0.0001* | - |
Mean serum creatinine, mmol/L ± SD | |||
Pretreatment | 6.8±2.2 | 6.7±1.9 | 0.9 |
Posttreatment | 1.9±0.7 | 1.7±0.5 | 0.4 |
P value | 0.0001* | 0.0001* | - |
Mean hemoglobin, g/L ± SD | |||
Preoperative | 12.6±1.6 | 12.6±1.9 | 0.9 |
Postoperative | 12.6±1.3 | 12.6±1.6 | 0.8 |
P value | 0.3 | 0.8 | - |
Mean serum pH, ± SD | |||
Pretreatment | 7.12±0.15 | 7.11±0.15 | 0.9 |
Posttreatment | 7.34±0.28 | 7.34±0.28 | 0.9 |
P value | 0. 001* | 0.001* | - |
Mean urinary output, mL/24h ± SD | |||
Pretreatment | 378.0±334.1 | 444.0±335.5 | 0.6 |
Posttreatment | 1602.0±380.2 | 1496.0±331.2 | 0.5 |
P value | 0.0001* | 0. 0001* | - |
ILIB, Intravascular laser irradiation of blood; NS, non-significant.
* Statistically significant.